Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jos Prickaerts

Showing results (31-40 of 170) with videos related to

Pageof 17
Sort By:
Pharmacology, Biochemistry, and Behavior|April 26, 2026
Temporal dynamics of PDE4 inhibition in modulating novel object recognition memory consolidation and reconsolidationJeferson Machado Batista Sohn, Letícia Guidi Ramalho, Jos Prickaerts, et al.
Behavioural Pharmacology|March 21, 2015
Continuous infusion of the α7 nicotinic acetylcholine receptor agonist EVP-6124 produces no signs of tolerance at memory-enhancing doses in rats: a pharmacokinetic and behavioral studyNick P van Goethem, Jos Prickaerts, Devin Welty, et al.
Neural Regeneration Research|July 28, 2022
A perspective on causality assessment in epigenetic research on neurodegenerative disordersPhilippos Koulousakis, Assia Tiane, Niels Hellings, et al.
Biophysical Journal|June 19, 2022
Computational investigation of the dynamic control of cAMP signaling by PDE4 isoform typesDean Paes, Sammy Hermans, Daniel van den Hove, et al.
Pharmacological Reviews|July 8, 2021
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and InhibitorsDean Paes, Melissa Schepers, Ben Rombaut, et al.
Psychopharmacology|January 5, 2005
Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidationJos Prickaerts, Ayhan Sik, Franz Josef van der Staay, et al.
Psychopharmacology|August 19, 2008
Selective phosphodiesterase inhibitors: a promising target for cognition enhancementOlga A H Reneerkens, Kris Rutten, Harry W M Steinbusch, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 17, 2020
The 5-HT<sub>1A</sub> receptor as a serotonergic target for neuroprotection in cerebral ischemiaRafael Pazinatto de Aguiar, Adrian Newman-Tancredi, Jos Prickaerts, et al.
Psychopharmacology|June 9, 2018
The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairmentLaura G J M Borghans, Anke Sambeth, Jos Prickaerts, et al.
Plos One|September 14, 2011
Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescenceIne Rayen, Daniël L van den Hove, Jos Prickaerts, et al.
Pageof 17

Showing results (31-40 of 170) with videos related to

Sort By:
Pageof 17
Pharmacology, Biochemistry, and Behavior|April 26, 2026
Temporal dynamics of PDE4 inhibition in modulating novel object recognition memory consolidation and reconsolidationJeferson Machado Batista Sohn, Letícia Guidi Ramalho, Jos Prickaerts, et al.
Behavioural Pharmacology|March 21, 2015
Continuous infusion of the α7 nicotinic acetylcholine receptor agonist EVP-6124 produces no signs of tolerance at memory-enhancing doses in rats: a pharmacokinetic and behavioral studyNick P van Goethem, Jos Prickaerts, Devin Welty, et al.
Neural Regeneration Research|July 28, 2022
A perspective on causality assessment in epigenetic research on neurodegenerative disordersPhilippos Koulousakis, Assia Tiane, Niels Hellings, et al.
Biophysical Journal|June 19, 2022
Computational investigation of the dynamic control of cAMP signaling by PDE4 isoform typesDean Paes, Sammy Hermans, Daniel van den Hove, et al.
Pharmacological Reviews|July 8, 2021
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and InhibitorsDean Paes, Melissa Schepers, Ben Rombaut, et al.
Psychopharmacology|January 5, 2005
Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidationJos Prickaerts, Ayhan Sik, Franz Josef van der Staay, et al.
Psychopharmacology|August 19, 2008
Selective phosphodiesterase inhibitors: a promising target for cognition enhancementOlga A H Reneerkens, Kris Rutten, Harry W M Steinbusch, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 17, 2020
The 5-HT<sub>1A</sub> receptor as a serotonergic target for neuroprotection in cerebral ischemiaRafael Pazinatto de Aguiar, Adrian Newman-Tancredi, Jos Prickaerts, et al.
Psychopharmacology|June 9, 2018
The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairmentLaura G J M Borghans, Anke Sambeth, Jos Prickaerts, et al.
Plos One|September 14, 2011
Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescenceIne Rayen, Daniël L van den Hove, Jos Prickaerts, et al.
Pageof 17